Impact of cholesterol metabolism and the LXRalpha-SREBP-1c pathway on nonalcoholic fatty liver disease.
Nakamuta M, Fujino T, Yada R, Yada M, Yasutake K, Yoshimoto T, Harada N, Higuchi N, Kato M, Kohjima M, Taketomi A, Maehara Y, Nakashima M, Kotoh K, Enjoji M.
Nakamuta M, et al.
Int J Mol Med. 2009 May;23(5):603-8. doi: 10.3892/ijmm_00000170.
Int J Mol Med. 2009.
PMID: 19360318